Month: May 2025

Post Content

The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn what physicians need to know about managing these patients. Medscape Medical News

More dermatology patients are taking the popular drugs, but little is known about the biology of “Ozempic face” or how best to treat it. Medscape Medical News

BRITS will be able to get Ozempic-style fat jabs from high street pharmacies, according to reports. Drugs like Mounjaro and Wegovy could be available over the counter after a short consultation at the cost of an NHS prescription, they claim. Getty Right now, only a few can get their hands on the powerful jabs – … Read more

Weight loss jabs, also known as GLP-1 receptor agonists and sold under brand names like Mounjaro and Wegovy, work by reducing food cravings.

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development for type 2 diabetes. Medscape Medical News

The World Health Organization (WHO) on Thursday announced its support for weight-loss drugs in adults globally. The organization plans to back GLP-1s like Wegovy and Zepbound to treat obesity in adults as part of a shift in addressing the global obesity epidemic, as reported by Reuters. In a memo, the agency called for strategies to … Read more

By TOM MURPHY, Associated Press Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound. CVS Health said the drugs Wegovy and Saxenda from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1. Zepbound … Read more